Results 21 to 30 of about 2,336,057 (277)

Co-amoxiclav-induced Stevens Johnson syndrome in a child [PDF]

open access: yesThe Pan African Medical Journal, 2013
Stevens-Johnson Syndrome is an uncommon life threatening disease generally induced by drugs. Antibiotics, mainly sulphonamides, are the most involved drugs in Stevens-Johnson Syndrome in children. Co-amoxiclav is a well tolerated antibiotic. It has never
Neila Fathallah   +6 more
doaj   +2 more sources

Risk of Stevens-Johnson Syndrome with AEDs

open access: yesPediatric Neurology Briefs, 1995
An international case-controlled study of medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis is reported by the Groupe Epidemiologie LY Stevens Johnson (ELYS), Department of Dermatology, and Department of Public Health,
J Gordon Millichap
doaj   +2 more sources

UK guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016

open access: yesJournal of Plastic, Reconstructive and Aesthetic Surgery, 2016
Catherine Smith   +2 more
exaly   +2 more sources

Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.

open access: yesJAMA dermatology, 2023
Importance Antibiotics are an important risk for Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN), which are the most severe types of drug hypersensitivity reaction with a mortality rate up to 50%.
E. Lee, C. Knox, E. Phillips
semanticscholar   +1 more source

Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome

open access: yesJAAD International, 2023
Background Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap syndrome are rare severe cutaneous adverse reactions associated with high mortality.
P. Wasuwanich   +4 more
semanticscholar   +1 more source

Ophthalmic Aspects of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Narrative Review

open access: yesOphthalmology and Therapy, 2023
The aim of our review article was to summarize the current literature on Stevens–Johnson syndrome (SJS) and its severe form, toxic epidermal necrolysis (TEN).
Gábor Tóth   +7 more
semanticscholar   +1 more source

Bronchiolitis obliterans associated with toxic epidermal necrolysis induced by infection: A case report and literature review

open access: yesFrontiers in Pediatrics, 2023
BackgroundStevens-Johnson syndrome/toxic epidermal necrolysis has a severe impact on patients' eyes, genital mucosa, and many other organs. Bronchiolitis obliterans is a rare complication of Stevens-Johnson syndrome/toxic epidermal necrolysis.Data ...
Jingwei Liu   +3 more
doaj   +1 more source

Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020

open access: yesFrontiers in Medicine, 2022
Background Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, life-threatening immunologic reactions. Prior studies using electronic health records, registries or reporting databases are often limited in sample size or lack ...
Liqin Wang   +8 more
semanticscholar   +1 more source

Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis

open access: yesFrontiers in Medicine, 2022
BackgroundVanishing bile duct syndrome is a rare drug-induced disease characterized by cholestasis and ensuing ductopenia. Dermatological manifestations of drug hypersensitivity such as Stevens-Johnson syndrome and toxic epidermal necrolysis may also ...
Wan-Chen Lin   +5 more
doaj   +1 more source

Neutrophils initiate and exacerbate Stevens–Johnson syndrome and toxic epidermal necrolysis

open access: yesScience Translational Medicine, 2021
Neutrophil extracellular traps induced by drug-specific CD8+ T cells initiate SJS/TEN. Skin-deep drug reactions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are similar life-threatening forms of severe cutaneous adverse drug ...
M. Kinoshita   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy